The Benefits and Risks of Using Positron Emission Tomography in Clinical Drug Development

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)37-42
    JournalDrug Development
    Volume5
    Publication statusPublished - 2010

    Cite this